The Future Is Now: The Evolution of Immunotherapy in Cancer
Sunday, June 5, 2016
Sheraton Grand Chicago • Chicago, Illinois
Presented by prIME Oncology in collaboration with the Society for Immunotherapy of Cancer
This satellite symposium, which was held during the 2016 ASCO Annual Meeting, examined the role of the immune system in cancer, the rationale for immunotherapy as a treatment for solid tumors, and the results from ongoing clinical trials of immunotherapies in various solid tumors. Attendees learned about the identification and management of treatment-related adverse events in patients receiving immunotherapy and about appropriate clinical trials of immunotherapies for patients with solid tumors.
Click here to learn more about this program!
Chair
Leisha A. Emens, MD, PhD – Johns Hopkins University
Session Speakers and Topics
| 6:30 – 6:40 p.m. |
Introduction: Why Immunotherapy?
Leisha A. Emens, MD, PhD – Johns Hopkins University |
| 6:40 – 8:25 p.m. |
Taking Immunotherapy to the Next Level: The Experts Speak |
| |
Head and Neck Cancer
Tanguy Seiwert, MD – University of Chicago |
| |
Breast Cancer
Leisha A. Emens, MD, PhD – Johns Hopkins University |
| |
Gastrointestinal Cancers
Michael A. Morse, MD, MHS – Duke University Medical Center |
| |
Genitourinary Cancers
Susan F. Slovin, MD, PhD – Memorial Sloan Kettering Cancer Center |
| |
Non-Small Cell Lung Cancer
Vassiliki A. Papadimitrakopoulou, MD – University of Texas MD Anderson Cancer Center |
| |
What's the Next Step? An Interactive Roundtable Discussion
Faculty and Audience |
| 8:25 – 8:30 p.m. |
Closing Remarks: prIME Points |
Continuing Education
prIME Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
prIME Oncology designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Information
This educational activity was supported by grants from Advaxis; Incyte; and Merck and Co, Inc.
Not an official event of the 2016 ASCO Annual Meeting
Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation